TSX:BHC (Bausch Health Companies Inc.)
About BHC
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Bausch Health Companies Inc. (TSX: BHC) Latest News
Investing
What a Return to Profits for Valeant Pharmaceuticals Intl Inc. Means
Investing
Was Bill Ackman Wrong to Sell His Stake in Valeant Pharmaceutical Intl Inc.?
Investing
1 Beaten-Up Stock With a Potential 50% Upside
Investing
What Canopy Growth Corp can Learn From Valeant Pharmaceuticals Intl Inc
Investing
Valeant Pharmaceuticals Intl Inc.: Is a Recovery Possible?
Investing
How Much Longer Should You Hold Shares of Valeant Pharmaceuticals Intl Inc.?
Investing
Could Valeant Pharmaceuticals Intl Inc. Go to $0?
Investing
Bombardier, Inc.: Gold-Plated Compensation But Not Much Else
Investing
With Ackman Gone, Has Valeant Pharmaceuticals Intl Inc. Hit Rock Bottom?
Investing
Is Valeant Pharmaceuticals Intl Inc. Canada’s Cheapest Stock?